weight loss, compounding and food and drug administration

Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss medications for people who are obese or who are overweight and have one weight-related health condition,
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US, according to the US Food and Drug Administration (FDA). That means that compounding pharmacies and outsourcing facilities that had been legitimately preparing their own versions of the drugs will no longer be permitted to do so.
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.
Compound versions of weight loss drugs will no longer be available, FDA rules
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available after a decision by the U.S. Food and Drug Administration. The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply.
HealthDay on MSN21h
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to ...
It Makes You Lose Weight. Now They Say It Curbs Alcohol Cravings. Is It Too Good to Be True?
But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...
New Discovery Promises Weight Loss Without Ozempic's Side Effects
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...
US FDA to Hold off Action on Weight-Loss Drug Copies Pending Court Ruling
In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...
European Medical Journal3d
Semaglutide Before Bariatric Surgery: Not the Weight Loss Boost Expected
A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...
Medical Xpress8d
Taking semaglutide before bariatric surgery does not improve weight loss or safety, study finds
Get Instant Summarized Text (Gist) Taking semaglutide before bariatric surgery does not enhance weight loss or safety outcomes compared to surgery alone. Patients who took semaglutide before ...
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
News Medical on MSN7d
Surgery first strategy could lead to better weight loss outcomes
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...
The Financial Express2d
Popular weight loss drugs Ozempic and Mounjaro hold potential to transform type 1 diabetes treatment: GlobalData
Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...